Life Spine Announces FDA Clearance of IRIS™ Anterior Cervical Plate (ACP) System

Published: May 07, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HOFFMAN ESTATES, Ill.--(BUSINESS WIRE)--Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to the IRIS Anterior Cervical Plate System.

The IRIS Anterior Cervical Plate incorporates a low profile plate with a zero-step integrated nitinol locking mechanism. The system promotes tactile and visual confirmations of final screw placement while simplifying instrumentation for intraoperative techniques.

Rita K. Patel, Life Spine’s Director of Marketing stated, “The IRIS ACP System adds to our comprehensive portfolio of intuitive cervical plating systems. This system will minimize steps and surgical time while providing reassurance in screw placement.”

IRIS is the sixth anterior cervical plate system within Life Spine’s cervical platform, which already consists of three static systems (NEO®, NEO-SL, NEO-UL) and two internally dynamizing systems (KINETIC® and KINETIC-SL).

About Life Spine

Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Hoffman Estates, Illinois. For more information, please visit


Life Spine
Mr. Omar Faruqi
Vice President of Strategic Planning

Back to news